Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: johny who wrote (393)	12/9/1997 12:01:00 PM
From: Jerry Feder	Read Replies (1) \| Respond to of 2068

Andreas, I think a simpler reason(less fanciful)are the 2 relatively negative articles in todays NY Times. And even they admit to mostly speculation on their part.

To: johny who wrote (393)	12/9/1997 12:12:00 PM
From: Andreas	Respond to of 2068

Johny, Maybe so. One thing is clear. Wiggins and his team are fighting on several fronts right now, which detracts from their ability to address business issues in a dedicated and concentrated way. These fights include (i) shareholder class action litigation, (ii) state of New York investigation, (iii) hounding by analysts, brokers, newspapers, etc. (iv) completion of audit. A press release updating the world would, in my view, go a long way to building confidence. A strong leader would come out, face the cameras and address some of the more nagging issues and rumors. Silence implies, in the minds of investors and prospective investors, that OXHP has little positive news to share. Another point, wait until the class is certified and discovery begins in earnest. Wiggins and other top management will be tied up in depositions, answering interrogatories, etc. etc. until hell freezes over. Which means they are not around to run the business. Wall Street understands this perfectly. There is a hidden cost to this litigation which is management distraction and detraction from the day to day affairs of Oxford. This will, in the minds and eyes of Wall Street analysts, result in inferior operating results. This is crisis time and the big issue is whether or not Wiggins et al. have the strength to endure, persevere and overcome. It's early yet, we have yet to see what OXHP's management is made of.